ImmersiveTouch, Leader of Metaverse, Obtains FDA Clearance for New Suite of Medical Diagnostic and Treatment Planning Tools | Illinois

CHICAGO – (BUSINESS WIRE) – November 30, 2021–

ImmersiveTouch, a leading medical technology company building the metaverse of digital surgery, today announced, in collaboration with RSNA 2021, that it has received 510 (k) clearance from the Food and Drug Administration (FDA) for its modular software package that allows users to import, view and automatically segment medical images to create precise three-dimensional representations. Giving surgeons the ability to diagnose and treat patients virtually will reduce planning hours and increase efficiency, which is crucial for physicians and patients.

Segmented 3D models can be used for medical diagnosis, anatomical measurement, treatment planning, and generation of output files for additive manufacturing. ImmersiveTouch is the first patient-specific automatic segmentation technology to generate virtual reality surgical plans that has been used in over 900 procedures this year and is currently deployed in nearly 70 leading hospitals.

Dr Matthew Ranzer, Doctor of Plastic Surgery at Mount Sinai Hospital, says: “One of the things I love about ImmersiveTouch is that it’s cheap, but it adds of value to our system. The ability to simulate these surgeries in great detail makes our operations more efficient and safer for our patients and provides a real benefit to our hospital and our community.

The health metaverse is on the rise. According to a study published by Facts and Factors, the size of the virtual reality in healthcare market is expected to grow by a CAGR of 34.89% to $ 40.98 billion by 2026, from 2.70 billion dollars in 2020.

“As the healthcare industry truly begins to embrace technological advancements, we are able to reduce surgical planning and operative times, improving surgical efficiency and minimizing workflow interruptions,” says Pat Banerjee , CEO of ImmersiveTouch.

ImmersiveTouch COO Jay Banerjee says, “Adding this additional FDA 510 (k) clearance for medical diagnostics and treatment planning to our portfolio only strengthens what ImmersiveTouch can. offer to surgeons. “

About ImmersiveTouch, Inc.

ImmersiveTouch enables clinicians to achieve greater precision and consistency of care by using technology to simulate each patient’s unique pathology in 3D through its immersive VR metaverse. The company’s proprietary platform integrates solutions for surgical planning, education and patient engagement.

View source version on

CONTACT: Lyne Flakus

[email protected]



SOURCE: ImmersiveTouch, Inc.

Copyright Business Wire 2021.

PUB: 11/30/2021 12:12 / DISC: 11/30/2021 12:12

Copyright Business Wire 2021.